{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:45:39Z","timestamp":1791391539564,"version":"4.3.3"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":412,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society (ACS)","doi-asserted-by":"publisher","award":["RSG-13\u2013287-01-TBE"],"award-info":[{"award-number":["RSG-13\u2013287-01-TBE"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences (NIGMS)","doi-asserted-by":"publisher","award":["GM128675"],"award-info":[{"award-number":["GM128675"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"HHS | NIH | National Cancer Institute (NCI)","doi-asserted-by":"publisher","award":["CA151112"],"award-info":[{"award-number":["CA151112"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Atol Charitable Trust","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1074\/mcp.ra119.001506","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T21:55:22Z","timestamp":1560376522000},"page":"1607-1618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Phosphoproteome Analysis Reveals Estrogen-ER Pathway as a Modulator of mTOR Activity Via DEPTOR"],"prefix":"10.1016","volume":"18","author":[{"given":"Rafael","family":"Cuesta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A.","family":"Gritsenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4076-151X","authenticated-orcid":false,"given":"Vladislav A.","family":"Petyuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6514-6911","authenticated-orcid":false,"given":"Chia-Feng","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9529-6550","authenticated-orcid":false,"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2961-2572","authenticated-orcid":false,"given":"Jason E.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5030-7973","authenticated-orcid":false,"given":"Marina K.","family":"Holz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.RA119.001506_bib1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1210\/er.2018-00087","article-title":"Estrogen Receptors: New Directions in the New Millennium","volume":"39","author":"Hewitt","year":"2018","journal-title":"Endocr. Rev"},{"key":"10.1074\/mcp.RA119.001506_bib2","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1530\/EJE-16-0124","article-title":"Mechanisms of oestrogen receptor (ER) gene regulation in breast cancer","volume":"175","author":"Carroll","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1074\/mcp.RA119.001506_bib3","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1210\/er.2010-0016","article-title":"Cracking the estrogen receptor's posttranslational code in breast tumors","volume":"32","author":"Le Romancer","year":"2011","journal-title":"Endocr. Rev"},{"key":"10.1074\/mcp.RA119.001506_bib4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1101\/gad.316646.118","article-title":"Signaling pathways and steroid receptors modulating estrogen receptor alpha function in breast cancer","volume":"32","author":"Siersbaek","year":"2018","journal-title":"Genes Dev"},{"key":"10.1074\/mcp.RA119.001506_bib5","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1200\/JCO.2010.34.4879","article-title":"Phosphatidylinositol 3-kinase and antiestrogen resistance in breast cancer","volume":"29","author":"Miller","year":"2011","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/mcp.RA119.001506_bib6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/MCB.00821-10","article-title":"Genomic collaboration of estrogen receptor alpha and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs","volume":"31","author":"Madak-Erdogan","year":"2011","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/mcp.RA119.001506_bib7","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1158\/1541-7786.MCR-13-0588","article-title":"Novel roles for ERK5 and cofilin as critical mediators linking ERalpha-driven transcription, actin reorganization, and invasiveness in breast cancer","volume":"12","author":"Madak-Erdogan","year":"2014","journal-title":"Mol. Cancer Res"},{"key":"10.1074\/mcp.RA119.001506_bib8","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1038\/onc.2015.414","article-title":"mTORC1 directly phosphorylates and activates ERalpha on estrogen stimulation","volume":"35","author":"Alayev","year":"2015","journal-title":"Oncogene"},{"key":"10.1074\/mcp.RA119.001506_bib9","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/jnci\/djj357","article-title":"Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis","volume":"98","author":"Mauri","year":"2006","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1074\/mcp.RA119.001506_bib10","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"Early Breast Cancer Trialists' Collaborative, G","year":"2011","journal-title":"Lancet"},{"key":"10.1074\/mcp.RA119.001506_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","article-title":"mTOR signaling in growth, metabolism, and disease","volume":"169","author":"Saxton","year":"2017","journal-title":"Cell"},{"key":"10.1074\/mcp.RA119.001506_bib12","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/jcp.24351","article-title":"mTOR signaling for biological control and cancer","volume":"228","author":"Alayev","year":"2013","journal-title":"J. Cell. Physiol"},{"key":"10.1074\/mcp.RA119.001506_bib13","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1038\/onc.2011.657","article-title":"Estrogenic regulation of S6K1 expression creates a positive regulatory loop in control of breast cancer cell proliferation","volume":"31","author":"Maruani","year":"2012","journal-title":"Oncogene"},{"key":"10.1074\/mcp.RA119.001506_bib14","doi-asserted-by":"crossref","first-page":"9461","DOI":"10.1158\/0008-5472.CAN-06-1895","article-title":"Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain","volume":"66","author":"Yu","year":"2006","journal-title":"Cancer Res"},{"key":"10.1074\/mcp.RA119.001506_bib15","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1074\/jbc.RA118.004383","article-title":"Estrogen receptor alpha promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f)","volume":"294","author":"Cuesta","year":"2019","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA119.001506_bib16","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1074\/jbc.M807532200","article-title":"S6 kinase 1 regulates estrogen receptor alpha in control of breast cancer cell proliferation","volume":"284","author":"Yamnik","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA119.001506_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.febslet.2009.11.041","article-title":"mTOR\/S6K1 and MAPK\/RSK signaling pathways coordinately regulate estrogen receptor alpha serine 167 phosphorylation","volume":"584","author":"Yamnik","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1074\/mcp.RA119.001506_bib18","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/bcr3660","article-title":"The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-alpha in human breast tumors in vivo","volume":"16","author":"Shrivastav","year":"2014","journal-title":"Breast Cancer Res"},{"key":"10.1074\/mcp.RA119.001506_bib19","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/me.2010-0373","article-title":"The IGF pathway regulates ERalpha through a S6K1-dependent mechanism in breast cancer cells","volume":"25","author":"Becker","year":"2011","journal-title":"Mol. Endocrinol"},{"key":"10.1074\/mcp.RA119.001506_bib20","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1109653","article-title":"Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"10.1074\/mcp.RA119.001506_bib21","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1200\/JCO.2011.39.0708","article-title":"Randomized phase II trial of everolimus in combination with tamoxifen in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer with prior exposure to aromatase inhibitors: a GINECO study","volume":"30","author":"Bachelot","year":"2012","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/mcp.RA119.001506_bib22","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1093\/annonc\/mdu456","article-title":"Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2dagger","volume":"25","author":"Piccart","year":"2014","journal-title":"Ann. Oncol"},{"key":"10.1074\/mcp.RA119.001506_bib23","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1152\/physrev.00064.2017","article-title":"DEPTOR at the nexus of cancer, metabolism, and immunity","volume":"98","author":"Caron","year":"2018","journal-title":"Physiol. Rev"},{"key":"10.1074\/mcp.RA119.001506_bib24","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2009.03.046","article-title":"DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival","volume":"137","author":"Peterson","year":"2009","journal-title":"Cell"},{"key":"10.1074\/mcp.RA119.001506_bib25","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nsmb.1995","article-title":"Histone H3 lysine 9 trimethylation and HP1gamma favor inclusion of alternative exons","volume":"18","author":"Saint-Andre","year":"2011","journal-title":"Nat. Struct. Mol. Biol"},{"key":"10.1074\/mcp.RA119.001506_bib26","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","article-title":"Molecular signatures database (MSigDB) 3.0","volume":"27","author":"Liberzon","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1074\/mcp.RA119.001506_bib27","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1021\/ac0262560","article-title":"Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS\/MS","volume":"75","author":"Thompson","year":"2003","journal-title":"Anal. Chem"},{"key":"10.1074\/mcp.RA119.001506_bib28","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1021\/acs.jproteome.5b00859","article-title":"Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts","volume":"15","author":"Tabb","year":"2016","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.RA119.001506_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1586\/epr.12.15","article-title":"High-pH reversed-phase chromatography with fraction concatenation for 2D proteomic analysis","volume":"9","author":"Yang","year":"2012","journal-title":"Expert Rev. Proteomics"},{"key":"10.1074\/mcp.RA119.001506_bib30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cell.2016.05.069","article-title":"Integrated proteogenomic characterization of human high grade serous ovarian cancer","volume":"166","author":"Zhang","year":"2016","journal-title":"Cell"},{"key":"10.1074\/mcp.RA119.001506_bib31","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1038\/ncomms6277","article-title":"MS-GF+ makes progress towards a universal database search tool for proteomics","volume":"5","author":"Kim","year":"2014","journal-title":"Nat. Commun"},{"key":"10.1074\/mcp.RA119.001506_bib32","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/nar\/gkp1188","article-title":"Location analysis for the estrogen receptor-alpha reveals binding to diverse ERE sequences and widespread binding within repetitive DNA elements","volume":"38","author":"Mason","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1074\/mcp.RA119.001506_bib33","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nrm.2016.122","article-title":"Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors","volume":"17","author":"Levin","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"10.1074\/mcp.RA119.001506_bib34","doi-asserted-by":"crossref","first-page":"21806","DOI":"10.18632\/oncotarget.15586","article-title":"Therapeutic sensitivity to Rac GTPase inhibition requires consequential suppression of mTORC1, AKT, and MEK signaling in breast cancer","volume":"8","author":"Hampsch","year":"2017","journal-title":"Oncotarget"},{"key":"10.1074\/mcp.RA119.001506_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4161\/21541248.2014.989789","article-title":"Crossroads of PI3K and Rac pathways","volume":"6","author":"Campa","year":"2015","journal-title":"Small GTPases"},{"key":"10.1074\/mcp.RA119.001506_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molcel.2011.03.017","article-title":"Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size","volume":"42","author":"Saci","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1074\/mcp.RA119.001506_bib37","first-page":"207","article-title":"Inhibition of the Rho GTPase, Rac1, decreases estrogen receptor levels and is a novel therapeutic strategy in breast cancer","volume":"18","author":"Rosenblatt","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1074\/mcp.RA119.001506_bib38","first-page":"e24911","article-title":"Interaction of JAK with steroid receptor function","volume":"2","author":"Gupta","year":"2013","journal-title":"JAKSTAT"},{"key":"10.1074\/mcp.RA119.001506_bib39","doi-asserted-by":"crossref","first-page":"4052","DOI":"10.1128\/MCB.01591-05","article-title":"Phosphorylation of JAK2 at serine 523: a negative regulator of JAK2 that is stimulated by growth hormone and epidermal growth factor","volume":"26","author":"Mazurkiewicz-Munoz","year":"2006","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/mcp.RA119.001506_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s42003-018-0028-4","article-title":"mTORC1 impedes osteoclast differentiation via calcineurin and NFATc1","volume":"1","author":"Huynh","year":"2018","journal-title":"Commun. Biol"},{"key":"10.1074\/mcp.RA119.001506_bib41","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1007\/s00018-008-8273-1","article-title":"Repression of NFAT3 transcriptional activity by estrogen receptors","volume":"65","author":"Qin","year":"2008","journal-title":"Cell Mol. Life Sci"},{"key":"10.1074\/mcp.RA119.001506_bib42","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/embor.2013.5","article-title":"The multifaceted role of mTORC1 in the control of lipid metabolism","volume":"14","author":"Ricoult","year":"2013","journal-title":"EMBO Rep"},{"key":"10.1074\/mcp.RA119.001506_bib43","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.molcel.2011.09.005","article-title":"mTOR generates an auto-amplification loop by triggering the betaTrCP- and CK1alpha-dependent degradation of DEPTOR","volume":"44","author":"Duan","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1074\/mcp.RA119.001506_bib44","doi-asserted-by":"crossref","first-page":"e113354","DOI":"10.1371\/journal.pone.0113354","article-title":"Estrogen induces global reorganization of chromatin structure in human breast cancer cells","volume":"9","author":"Mourad","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1074\/mcp.RA119.001506_bib45","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neo.2015.02.003","article-title":"Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression","volume":"17","author":"Parvani","year":"2015","journal-title":"Neoplasia"},{"key":"10.1074\/mcp.RA119.001506_bib46","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1038\/s41375-018-0037-9","article-title":"Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups","volume":"32","author":"Bolli","year":"2018","journal-title":"Leukemia"},{"key":"10.1074\/mcp.RA119.001506_bib47","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","author":"Cancer Genome Atlas, N","year":"2012","journal-title":"Nature"},{"key":"10.1074\/mcp.RA119.001506_bib48","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1158\/1541-7786.MCR-08-0107","article-title":"Genetic alterations and oncogenic pathways associated with breast cancer subtypes","volume":"7","author":"Hu","year":"2009","journal-title":"Mol. Cancer Res"},{"key":"10.1074\/mcp.RA119.001506_bib49","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-med-070909-182917","article-title":"Mechanisms of endocrine resistance in breast cancer","volume":"62","author":"Osborne","year":"2011","journal-title":"Annu. Rev. Med"},{"key":"10.1074\/mcp.RA119.001506_bib50","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/bcr2594","article-title":"Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer","volume":"12","author":"Creighton","year":"2010","journal-title":"Breast Cancer Res"},{"key":"10.1074\/mcp.RA119.001506_bib51","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5306\/wjco.v9.i8.172","article-title":"Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer","volume":"9","author":"Sobhani","year":"2018","journal-title":"World J. Clin. Oncol"},{"key":"10.1074\/mcp.RA119.001506_bib52","doi-asserted-by":"crossref","first-page":"D442","DOI":"10.1093\/nar\/gky1106","article-title":"The PRIDE database and related tools and resources in 2019: improving support for quantification data","volume":"47","author":"Perez-Riverol","year":"2019","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620340615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620340615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.RA119.001506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:57:25Z","timestamp":1761526645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620340615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1535947620340615"],"URL":"https:\/\/doi.org\/10.1074\/mcp.ra119.001506","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phosphoproteome Analysis Reveals Estrogen-ER Pathway as a Modulator of mTOR Activity Via DEPTOR","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.RA119.001506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Cuesta et al.","name":"copyright","label":"Copyright"}]}}